GeorgeE.DaileyIIIMD

PubMed

• 4 citations
  Primary Care Physicians’ Knowledge of the Cardiovascular Effects of Diabetes Medications: Findings from an Online Survey
  Jonathan Pak, George Dailey> ;Advances in Therapy. 2020 Jul 4
• 4 citations
  Efficacy and safety of lixisenatide as add-on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal-O Study.
  George Dailey, Terry Dex, Michelle Roberts, Minzhi Liu, Graydon S. Meneilly> ;Journal of Diabetes. 2019 Dec 1
• 23 citations
  Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide.
  Julio Rosenstock, Christopher H. Sorli, Michael E. Trautmann, Cristobal Morales, Ulrich Wendisch, George Dailey, Marcus Hompesch, In Young Choi, Jahoon Kang, John A. S...> ;Diabetes Care. 2019 Sep 1
• 2 citations
  Post hoc efficacy and safety analysis of insulin glargine/lixisenatide fixed- ratio combination in North American patients compared with the rest of world
  George Dailey, Harpreet S. Bajaj, Terry Dex, Mélanie Groleau, William Stager, Aaron I. Vinik> ;BMJ Open Diabetes Research & Care. 2019 Mar 1
• 1 citations
  Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargin...
  George Dailey, Timothy Reid, John R. White, Jason Chao, Fang L. Zhou, Sachin Paranjape, Paulos Berhanu> ;Endocrinology, Diabetes & Metabolism. 2018 Sep 21
• 21 citations
  Lixisenatide Therapy in Older Patients With Type 2 Diabetes Inadequately Controlled on Their Current Antidiabetic Treatment: The GetGoal-O Randomized Trial.
  Graydon S. Meneilly, Christine Roy-Duval, Hasan Alawi, George Dailey, Diego Bellido, Carlos Trescoli, Helard Manrique Hurtado, Hailing Guo, Valerie Pilorget, Riccardo ...> ;Diabetes Care. 2017 Apr 1
• 3 citations
  A novel option for prandial insulin therapy: inhaled insulin.
  George Dailey, Aakif Ahmad, Sarit Polsky, Viral N. Shah> ;Postgraduate Medicine. 2016 Sep 27
• 7 citations
  A review of the safety and efficacy data for insulin glargine 300 units/ml, a new formulation of insulin glargine
  George Dailey, F. Lavernia> ;Diabetes, Obesity & Metabolism. 2015 Dec 1
• 5 citations
  Empagliflozin: a new treatment option for patients with type 2 diabetes mellitus.
  Dailey, G. E.> ;Drugs of today (Barcelona, Spain : 1998). 2015 Oct 22
• 6 citations
  Recognizing and minimizing hypoglycemia: The need for individualized care
  Frank Lavernia, Pamela R. Kushner, Dace L. Trence, Donna Rice, George Dailey, Louis Kuritzky> ;Postgraduate Medicine. 2015 Sep 10
• 10 citations
  Empagliflozin for the treatment of type 2 diabetes mellitus: An overview of safety and efficacy based on Phase 3 trials.
  George Dailey> ;Journal of Diabetes. 2015 Jul 1
• 11 citations
  A Review of Cardiovascular Outcomes in the Treatment of People with Type 2 Diabetes
  George Dailey, Edward Wang> ;Diabetes Therapy. 2014 Dec 17
• 13 citations
  Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes
  Charles F. Shaefer, Timothy Reid, George Dailey, Melanie E. Mabrey, Aleksandra Vlajnic, Andreas Stuhr, John Stewart, Rong Zhou> ;Postgraduate Medicine. 2014 Oct 1
• 10 citations
  Comparison of three algorithms for initiation and titration of insulin glargine in insulin-naive patients with type 2 diabetes mellitus.
  George Dailey, Lisa Aurand, John A. Stewart, Barbara Ameer, Rong Zhou> ;Journal of Diabetes. 2014 Mar 1
• 6 citations
  Diabetes duration and the efficacy and safety of insulin glargine versus comparator treatment in patients with type 2 diabetes mellitus.
  Satish K. Garg, Lisa Aurand, Michael S. Rimler, George Dailey> ;Endocrine Practice. 2014 Feb 1
• 12 citations
  Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin.
  George Dailey, L. Gao, Lisa Aurand, Satish K. Garg> ;Diabetes, Obesity & Metabolism. 2013 Dec 1
• 71 citations
  Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study: Results from the 6-month continuation phase
  Richard M. Bergenstal, William V. Tamborlane, Andrew J. Ahmann, John B. Buse, George Dailey, Stephen N. Davis, Carol Joyce, Bruce A. Perkins, John B. Welsh, Steven M. ...> ;Diabetes Care. 2011 Nov 1
• 68 citations
  Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes.
  David C. Klonoff, Lawrence Blonde, George S. Cembrowski, Antonio Roberto Chacra, Guillaume Charpentier, Stephen Colagiuri, George Dailey, Robert A. Gabbay, Lutz Heinem...> ;Journal of Diabetes Science and Technology. 2011 Nov 1
• 36 citations
  Overall Mortality in Diabetes Mellitus: Where Do We Stand Today?
  George Dailey> ;Diabetes Technology & Therapeutics. 2011 Jun 13
• 47 citations
  Early and Intensive Therapy for Management of Hyperglycemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
  George Dailey> ;Clinical Therapeutics. 2011 Jun 1
• 10 citations
  Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience.
  John B. Buse, George Dailey, Andrew A. Ahmann, Richard M. Bergenstal, Jennifer B. Green, Tim Peoples, Robert J. Tanenberg, Qingqing Yang> ;Diabetes Technology & Therapeutics. 2011 May 25
• 35 citations
  Relationship of Insulin Dose, A1c Lowering, and Weight in Type 2 Diabetes: Comparing Insulin Glargine and Insulin Detemir
  George Dailey, Karim Admane, Florence Mercier, David R. Owens> ;Diabetes Technology & Therapeutics. 2010 Dec 4
• 8 citations
  Pulsatile intermittent intravenous insulin therapy for attenuation of retinopathy and nephropathy in type 1 diabetes mellitus.
  Larry A. Weinrauch, Jennifer K. Sun, Ray E. Gleason, Guenther Boden, R.H. Creech, George Dailey, Frank P. Kennedy, Matthew R. Weir, John A. D'Elia> ;Metabolism. 2010 Oct 1
• 561 citations
  Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
  Richard M. Bergenstal, William V. Tamborlane, Andrew J. Ahmann, John B. Buse, George Dailey, Stephen N. Davis, Carol Joyce, Tim Peoples, Bruce A. Perkins, John B. Wels...> ;The New England Journal of Medicine. 2010 Jul 21
• 30 citations
  Do estrogens improve bone mineral density in osteoporotic women over age 65
  Christopher W. Marx, George E. Dailey, Carol Cheney, Vinton C. Vint, Douglas B. Muchmore> ;Journal of Bone and Mineral Research. 2010 Mar 3
• Join now to see all

Journal Articles

• A Novel Option for Prandial Insulin Therapy  
  Dailey, G, Ahmad, A, Polsky, S and Shah,V, Postgraduate Medicine, 1/1/2016
• A Review of Cardiovascular Outcomes in the Treatment of People with Type 2 Diabetes  
  Dailey, G, Diabetes Therapy, 1/1/2015
• Empagliflozin for treatment of type 2 diabetes mellitus: A review of Phase 3 trials  
  Dailey, G, Journal of Diabetes, 1/1/2015
• Empagliflozin: A New Treatment Option for Patients with Type 2 Diabetes  
  Dailey, G, Drugs of Today, 1/1/2015
• A review of the safety and efficacy data for new insulin Glargine, 300 units/ml, a new formulation of insulin glargine  
  Dailey, G and Lavernia, F, Diabetes, Obesity and Metabolism, 1/1/2015
• Recognizing and minimizing hypoglycemia: The need for individualized care  
  Lavernia, FA, Kushner, P, Trence, Dace. Rice. D, Dailey. George and Kuritsky, L, Postgraduate Medicine, 1/1/2015
• The Effect of Diabetes Duration on the Efficacy and Safety of Insulin Glargine and Comparator Treatment in Patient with Type 2 Diabetes  
  Garg, S, Aurand, L, Rimler, M and Dailey, G, Endocrine Practice, 1/1/2014
• Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes  
  Schaefer, CF, Reid, TS, Dailey, GE, Mabrey, ME, Vlajnic, A, Stuhr, A, Stewart, J and Zhou, R, Postgraduate Medicine, 1/1/2014
• Efficacy and Safety of basal-bolus regimen of basal insulin plus insulin glulisine in patients with type 2 diabetes: a pooled analysis of five clinical trials  
  Dailey, G, Mullins, P., Cali, A, Journal of Diabetes, 1/1/2014
• Comparison of Three Algorithms for Initiation of Insulin Glargine in Insulin-naïve Patients with Type 2 Diabetes Mellitus  
  Dailey, GE, Aurand, L, Stewart, J, Ameer, B, and Zhou, Z, Journal of Diabetes, 1/16/2013
• Impact of diabetes duration on hypoglycemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin  
  Dailey, G.E., Gao, L., Aurand, L., Garg, S.K., Diabetes, Obesity and Metabolism, 1/1/2013
• Baseline Predictors of A1c Reduction in Adults using Sensor-Augmented Pump Therapy or Multiple Dailey Injection Therapy: The STAR 3 Experience  
  Buse, John, Dailey. George, et al, Diabetes Technology & Therapeutics, 1/1/2011
• Over-all Mortality in Diabetes Mellitus: Where Do We Stand Today?  
  Dailey, George, Diabetes Technology & Therapeutics supplement, 1/1/2011
• Early and Intensive Therapy for Management of Hyperglycemia and Cardiovascular Risk Factors in Patients with Type 2 Diabetes  
  Dailey, George, Clinical Therapeutics, 1/1/2011
• Sensor-Augmented Pump Therapy for A1c Reduction: Results from the 6-month continuation phase  
  Bergenstal, RM, Tamborlane, WM, Ahman, A, Buse, JB, Dailey, G, Davis,S, Joyce, C, Perkins, BA, Welsh, JB, Willi, SM, Wood, MA for the STAR Study Group, Diabetes Care, 1/1/2011
• Duration of diabetes and hypoglycemia rates in Type 2 Diabetes patients treated with insulin glargine vs NPH  
  Dailey, G, Aurand ,L , Garg, S, Diabetologia, 1/1/2011
• Consensus Report: The Current Role of Self-Monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetics  
  Klonoff,DC, Blonde, L, Cembrowski, G, Chacra, AR, Charpentier, G, Colagiuri, S, Dailey, G, Gabbay, R, Heineman, L, Kerr, D, Nicolucci, A, Polonsky, W, Schnell, O, Vige..., Journal of Diabetes Science and Technology, 1/1/2011
• The effects of baseline characteristics, glycaemic treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycemia: post hoc epidemiologi...  
  Miller, ME, Dailey, G., et al, BMJ online, 1/8/2010
• Pulsatile intermittent insulin therapy for attenuation of retinopathy and nephropathy in type 1 diabetes mellitus  
  Weinrauch,Lawrence … Dailey,G, et al, Metabolism Clinical and Experimental, 1/1/2010
• Relationship of HbA1c lowering and weight change in Type 2 diabetes: Comparing insulin glargine with insulin detemir  
  Dailey, George, Owens, D, Admane, K and Mercier, F, Diabetes Technology and Therapeutics, 1/1/2010
• Effectiveness of Sensor-Augmented Insulin Pump Therapy in Type 1 Diabetes  
  Bergenstal, R, Tamborlane,W, Ahman, A, Dailey, G, Davis, SA, Joyce, J, Peoples, T, Perkins, BA, Welsh, JB, Willi, SM, and Wood, MD …et al, New England Journal of Medicine, 1/1/2010
• Comparing Insulin Galrgine with Insulin Detemir Effects of A1c Change on Weight and Insulin Dose in Patients with Type 2 Diabetes  
  Dailey, George, Admane, Karim, Mercier, Florence, and Owens, David, Diabetes, 1/1/2009
• Effect of Pulsatile Insulin Infusion on the Progression of Retinopathy in Type 1 Diabetes with Nephropathy: A Pilot Study  
  Weinrach, L, Sun, J, Gleason, R, Boden, G, Dailey, G, Kennedy, F, Weir, M, Creech, R and D'Elia, J, Diabetes, 1/1/2009
• Reconsideration of Severe Hypoglycemia in the Treat-To-Target Trial  
  Dailey, George, Strange, Poul and Riddle, Matthew, Diabetes Technology and Therapeutics, 1/1/2009
• Lower Risk of Severe Hypoglycemia with Use of Insulin Glargine vs NPH in Type 2 Diabetes: Review of Prospective and Retrospective Data  
  Dailey George & Strange, Poul, American Journal of Managed Care, 1/1/2008
• Join now to see all

Books/Book Chapters

• Conn's Current Therapy 
  Dailey GE1999
• Current Clinical Practice 
  Chapter: Hormones and cancer 
  Dailey GEW.B. Saunders Co., Philadelphia, PA1987

Other

• Recent Clinical Data on the Use of GLP-1 Analogs in Type 2 Diabetes: What Have We Learned? 
  Etie Moghissi, George Dailey; Edward Horton, Charles A. Reasner, Medscape
  1/17/2009
• Improving Oral Pharmacologic Therapy and Management for Type 2 Diabetes: Potential Impact on Health Care in the United States 
  Dailey, George, Care Magazine
  1/1/2004
• Advances in Diabetes for the Millennium: Understanding Insulin Resistance 
  Gerich, JE and Dailey, G, Medscape internet symposium
  1/1/2004
• Insulin in the Management of Type and Type 2 Diabetes 
  Hirsch, Irl and Dailey, George, Clinical Portfolio, published by Adelphi, Inc., Monograph and guidebook
  New York, NY - 1/1/2003
• Join now to see all